doi: 10.1161/hs0901.095408
(Stroke. 2001;32:2164.)
© 2001 American Heart Association, Inc.
Original Contributions |
Acute Tissue Damage After Injections of Thrombin and Plasmin into Rat Striatum
From the Department of Pathology and Manitoba Institute of Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Correspondence to Marc R. Del Bigio, MD, PhD, FRCPC, Department of Pathology, University of Manitoba, D212-770 Bannatyne Ave, Winnipeg, MB, R3E 0W3, Canada. E-mail delbigi{at}cc.umanitoba.ca
Background and Purpose—— Extravasation of blood is associated with intracerebral hemorrhage and head trauma. The mechanism of brain cell injury associated with hemorrhage differs from that due to pure ischemia. The purpose of this study was to investigate the acute changes after intracerebral injections of proteins that are involved in blood clotting and clot lysis.
Methods—— Sixty-eight adult rats were subjected to stereotaxic intrastriatal injections of normal saline (5 µL), low- (2.5 U/5 µL) and high-dose (25 U/5 µL) thrombin, low- (0.1 µg/5 µL) and high-dose (1 µg/5 µL) tissue plasminogen activator, low- (0.05 U/5 µL) and high-dose (0.5 U/5 µL) plasminogen, and low- (0.335 U/5 µL) and high-dose (3.35 U/5 µL) plasmin. Forty-eight hours later rats were perfusion fixed. Brain damage area, eosinophilic neurons, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)-positive cells, infiltrating neutrophils, CD8a immunoreactive leukocytes, and reactive microglia were quantified.
Results—— Damage area in striatum, dying cells, inflammatory cells, and microglial reaction were significantly greater after the high-dose plasminogen, plasmin, and thrombin injections. Tissue plasminogen activator injections were associated with mild inflammation.
Conclusions—— These results suggested that thrombin and plasmin are harmful to brain cells in vivo. Although the doses required to cause damage are relatively great in consideration of the plasma content of these proteins, their pathological effect might be enhanced through synergism with other mechanisms.
Key Words: blood coagulation • cerebral hemorrhage • leukocytes • microglia • proteolysis
This article has been cited by other articles:
 |
|
 |
|
  M. Xue, M. D. Hollenberg, A. Demchuk, and V. W. Yong Relative Importance of Proteinase-Activated Receptor-1 Versus Matrix Metalloproteinases in Intracerebral Hemorrhage-Mediated Neurotoxicity in Mice Stroke, June 1, 2009; 40(6): 2199 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yuan, K. M. Vance, C. E. Junge, M. T. Geballe, J. P. Snyder, J. R. Hepler, M. Yepes, C.-M. Low, and S. F. Traynelis The Serine Protease Plasmin Cleaves the Amino-terminal Domain of the NR2A Subunit to Relieve Zinc Inhibition of the N-Methyl-D-aspartate Receptors J. Biol. Chem., May 8, 2009; 284(19): 12862 - 12873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, J. Grotta, N. Gonzales, and J. Aronowski Hematoma Resolution as a Therapeutic Target: The Role of Microglia/Macrophages Stroke, March 1, 2009; 40(3_suppl_1): S92 - S94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Schneider and B. E. Sobel A Novel Role for Tissue-Type Plasminogen Activator: Prevention of Thromboembolic Occlusion Circulation, September 30, 2008; 118(14): 1408 - 1409. [Full Text] [PDF]
|
|
|
|
|
|
D. Strbian, M.-L. Karjalainen-Lindsberg, P. T. Kovanen, T. Tatlisumak, and P. J. Lindsberg Mast Cell Stabilization Reduces Hemorrhage Formation and Mortality After Administration of Thrombolytics in Experimental Ischemic Stroke Circulation, July 24, 2007; 116(4): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Ardizzone, X. Zhan, B. P. Ander, and F. R. Sharp Src Kinase Inhibition Improves Acute Outcomes After Experimental Intracerebral Hemorrhage Stroke, May 1, 2007; 38(5): 1621 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Xue, M. D. Hollenberg, and V. Wee Yong Combination of Thrombin and Matrix Metalloproteinase-9 Exacerbates Neurotoxicity in Cell Culture and Intracerebral Hemorrhage in Mice J. Neurosci., October 4, 2006; 26(40): 10281 - 10291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-T. Hong, J. Huang, and B. R. Lucchesi Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H959 - H967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
NINDS ICH Workshop Participants Priorities for Clinical Research in Intracerebral Hemorrhage: Report From a National Institute of Neurological Disorders and Stroke Workshop Stroke, March 1, 2005; 36(3): e23 - e41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Belayev, I. Saul, R. Busto, K. Danielyan, A. Vigdorchik, L. Khoutorova, and M. D. Ginsberg Albumin Treatment Reduces Neurological Deficit and Protects Blood-Brain Barrier Integrity After Acute Intracortical Hematoma in the Rat Stroke, February 1, 2005; 36(2): 326 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U.-K. Hanisch, D. van Rossum, Y. Xie, K. Gast, R. Misselwitz, S. Auriola, G. Goldsteins, J. Koistinaho, H. Kettenmann, and T. Moller The Microglia-activating Potential of Thrombin: THE PROTEASE IS NOT INVOLVED IN THE INDUCTION OF PROINFLAMMATORY CYTOKINES AND CHEMOKINES J. Biol. Chem., December 10, 2004; 279(50): 51880 - 51887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Boven, N. Vergnolle, S. D. Henry, C. Silva, Y. Imai, J. Holden, K. Warren, M. D. Hollenberg, and C. Power Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis J. Immunol., March 1, 2003; 170(5): 2638 - 2646. [Abstract] [Full Text] [PDF]
|
|